Skip to main content
. 2020 Dec 3;14:601063. doi: 10.3389/fnins.2020.601063

TABLE 1.

Demographics, clinical information, and neurocognitive performance.

Variable Control (n = 46) GDS normal (n = 55) GDS impaired (n = 36) P-value
Age (mean ± SD) 34.4 ± 6.7 32.0 ± 7.2 30.8 ± 7.1 0.057a
Male, n (%) 42 (91.3%) 54 (98.2%) 36 (100.0%) 0.089d
Education years (mean ± SD) / 13.0 ± 3.7 14.3 ± 2.7 0.060b
CD4 + T (mean ± SD) / 473.9 ± 233.3 496.2 ± 208.3 0.643b
CD4/CD8 (mean ± SD) / 0.6 ± 0.4 0.6 ± 0.5 0.982b
TND, n (%) / 30 (85.7%) 18 (81.8%) 0.722d
BMI (mean ± SD) / 21.1 ± 2.7 22.4 ± 2.6 0.031b
Hepatitis B virus infection, n (%) / 13 (26.5%) 9 (26.5%) 1.000c
Hepatitis C virus infection, n (%) / 1 (2.0%) 0 (0.0%) 1.000d
Syphilis, n (%) / 19 (34.5%) 16 (44.4%) 0.383c
TIV (mean ± SD) 1,507.7 ± 132.8 1,528.2 ± 120.1 1,553.0 ± 100.9 0.240a
Neurocognitive performance T scores (mean ± SD)
Speed of information processing / 48.4 ± 7.2 40.8 ± 9.5 < 0.001b
Memory (learning and recall) / 46.8 ± 6.5 39.1 ± 7.7 < 0.001b
Abstraction/executive / 58.4 ± 9.1 51.9 ± 8.6 0.001b
Attention/working memory / 44.8 ± 7.2 38.2 ± 6.9 < 0.001b
Fine motor skills / 48.4 ± 7.7 41.2 ± 11.8 0.001b
verbal and language / 48.7 ± 7.0 39.8 ± 9.6 < 0.001b
GDS / 0.1 ± 0.1 0.8 ± 0.8 < 0.001b

TND, virus not detectable; BMI, body mass index; TIV, total intracranial volume; GDS, global deficit score.P-value for comparison among three groups (age, male%, TIV) and between GDS normal and GDS impaired subgroups.Statistical tests including: aone-way ANOVA; bt-test; cchi-square test; dFisher’s exact test.